ChromaDex(CDXC)
Search documents
ChromaDex(CDXC) - 2021 Q3 - Quarterly Report
2021-11-02 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 Commission File Number: 001-37752 CHROMADEX CORPORATION (Exact Name of Registrant as Specified in its Charter) | --- | --- | --- | |----------------------------------------------------------------------------------|----------------------------|---------------------------------------------- ...
ChromaDex(CDXC) - 2021 Q2 - Earnings Call Presentation
2021-08-04 08:49
ChromaDex Earnings Conference Call Second Quarter 2021 Rob Fried Chief Executive Officer Frank Jaksch Co-Founder / Executive Chairman Kevin Farr Chief Financial Officer Nasdaq: CDXC | August 3, 2021 1 SAFE HARBOR STATEMENT This presentation and other written or oral statements made from time to time by representatives of ChromaDex contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-l ...
ChromaDex(CDXC) - 2021 Q2 - Earnings Call Transcript
2021-08-04 03:10
ChromaDex Corporation (NASDAQ:CDXC) Q2 2021 Earnings Conference Call August 3, 2021 4:30 PM ET Company Participants Brianna Gerber - Investor Relations Rob Fried - Chief Executive Officer Kevin Farr - Chief Financial Officer Frank Jaksch - Founder and Executive Chairman Conference Call Participants Brian Nagel - Oppenheimer Jeffrey Cohen - Ladenburg Raghuram Selvaraju - H.C. Wainwright Jeff Van Sinderen - B. Riley Mitch Pinheiro - Sturdivant JP Mark - Farmhouse Equity Operator Ladies and gentlemen, thank yo ...
ChromaDex(CDXC) - 2021 Q2 - Quarterly Report
2021-08-02 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 Commission File Number: 001-37752 CHROMADEX CORPORATION (Exact Name of Registrant as Specified in its Charter) | --- | --- | --- | |----------------------------------------------------------------------------------|----------------------------|--------------------------------------------------- ...
ChromaDex(CDXC) - 2021 Q1 - Earnings Call Transcript
2021-05-09 03:25
ChromaDex, Corp. (NASDAQ:CDXC) Q1 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants Brianna Gerber - VP of FP&A, IR Robert Fried - CEO Kevin Farr - CFO Frank Jaksch - Founder, EC Conference Call Participants J. P. Mark - Farmhouse Equity Research Michel Pinero - Sturdevant Operator Ladies and gentlemen, thank you for standing by and welcome to ChromaDex Corporation's First Quarter 2021 Earnings Conference Call. My name is Stephanie and I will be your conference operator today. At thi ...
ChromaDex(CDXC) - 2021 Q1 - Quarterly Report
2021-05-05 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 Commission File Number: 001-37752 CHROMADEX CORPORATION (Exact Name of Registrant as Specified in its Charter) | --- | |-----------------------------------------| | Delaware | | (State or other jurisdiction of | | incorporation or organization) | | --- | |---------------------| | | | | | 26-29 ...
ChromaDex(CDXC) - 2020 Q4 - Earnings Call Presentation
2021-03-11 21:18
ChromaDex Earnings Conference Call Fourth Quarter 2020 Rob Fried Chief Executive Officer Frank Jaksch Co-Founder / Executive Chairman Kevin Farr Chief Financial Officer Nasdaq: CDXC | March 10, 2021 1 SAFE HARBOR STATEMENT This presentation and other written or oral statements made from time to time by representatives of ChromaDex contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-l ...
ChromaDex(CDXC) - 2020 Q4 - Annual Report
2021-03-11 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware 26-2940963 (State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.) Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $0.001 par value per share CDXC The Nasdaq Capital Market Large accelerated filer ☐ Non-accelerated filer ☒ Accelerated filer ☐ Smaller reporting company ☒ Emerging growth company ☐ FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH ...
ChromaDex(CDXC) - 2020 Q4 - Earnings Call Transcript
2021-03-11 04:12
ChromaDex Corporation (NASDAQ:CDXC) Q4 2020 Earnings Conference Call March 10, 2021 4:30 PM ET Company Participants Brianna Gerber – Vice President-Finance and Investor Relations Rob Fried – Chief Executive Officer Frank Jaksch – Co-Founder and Executive Chairman Kevin Farr – Chief Financial Officer Conference Call Participants Brian Nagel – Oppenheimer Thomas Yip – H.C. Wainwright Destiny Buch – Ladenburg Thalmann Mitch Pinheiro – Sturdivant & Co. Jeff Van Sinderen – B. Riley Bill Dezellem – Tieton Capital ...
ChromaDex Corporation (CDXC) Investor Presentation - Slideshow
2020-12-14 18:19
Investor Presentation Rob Fried Chief Executive Officer Kevin Farr Chief Financial Officer TRU NIAGEN® Nasdaq: CDXC | December 2020 1 SAFE HARBOR STATEMENT This presentation and other written or oral statements made from time to time by representatives of ChromaDex contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements reflect the current view about future events. Sta ...